Milestone Pharmaceuticals's total assets for Q1 2026 were $193.73M, an increase of 70.60% from the previous quarter. MIST total liabilities were $157.69M for the fiscal quarter, a 119.64% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.